A recent meta-analysis of several CVOTs investigated the effects of GLP-1 RAs and DPP-4 inhibitors on the incidence of acute pancreatitis compared to a placebo or active comparators
However, in early May 2025, court rulings upheld the FDAs decision to end the sales of compounded tirzepatide
High-risk patient factors include active gastrointestinal symptoms (odds ratio 7.66, 95% confidence interval 3.4217.17), early treatment phase (less than 4 weeks), higher medication doses, pre-existing diabetic gastroparesis, obesity (BMI greater than 30), and gastroesophageal reflux disease [31]
It found that four out of 10 patients with B12 deficiency self-medicate via injection
The Fit50 Weight Loss Program is a comprehensive approach to wellness, targeting individuals over 50
Skin Conditions or Dehydration: Dry or irritated skin can heighten injection discomfort